ArticleBasic and clinical neuroscience2025
Altered Pain, Emotion, and Stress in Adulthood: Neurobehavioral and Neuroendocrine Consequences of Adolescent Morphine Exposure.
Article in Basic and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adolescence is a pivotal developmental stage characterized by increased susceptibility to opioid exposure, which can result in enduring modifications in pain sensitivity, emotional behavior, and stress regulation. This study aimed to examine the long-term effects of adolescent morphine exposure on nociception, anxiety- and depression-like behaviors, and plasma corticosterone levels in adulthood, employing a within-subject design to investigate behavioral and neuroendocrine correlations. Methods: Adolescent rats were administered increasing doses of morphine (2.5-25 mg/kg, s.c.) twice daily from postnatal day (PND) 31-40. Following a 20-day drug-free washout period, behavioral assessments were conducted between PND 60 and 65. Anxiety-like behavior was evaluated using the open field and elevated zero maze (EZM) tests, nociceptive sensitivity was assessed using the Hargreaves and Von-Frey tests, and depression-like behavior was measured using the forced swimming test (FST). Serum corticosterone levels were quantified 30 minutes after the FST. Principal component analysis (PCA) was also applied to standardized behavioral measures from morphine- and saline-treated animals to identify treatment-specific clustering and key behavioral contributors. Results: Adolescent morphine exposure reduced anxiety-like behavior, pain sensitivity, and serum corticosterone levels, while increasing depression-like behavior in adulthood. Paw withdrawal latency (PWL) was negatively correlated with open arm entries and time spent in the EZM, and immobility time in the FST. A positive correlation was observed between PWL and serum corticosterone levels. PCA of adult behavioral measures revealed distinct clustering of adolescent morphine- and saline-treated animals, indicating persistent treatment-specific behavioral profiles. Conclusion: These findings suggest that adolescent morphine exposure induces long-lasting alterations in behavioral profile, including pain sensitivity, emotional behavior, and stress hormone regulation. The observed correlations between nociceptive thresholds, emotional behaviors, and corticosterone levels highlight the complex interplay between opioid exposure, affective states, and neuroendocrine function in adulthood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.